共 50 条
- [42] Promising switch to anastrozole for breast-cancer treatmentLANCET ONCOLOGY, 2005, 6 (09): : 644 - 644Chen, V
- [43] Anastrozole for adjuvant treatment of breast cancer - Commentary 2STRAHLENTHERAPIE UND ONKOLOGIE, 2003, 179 (03) : 205 - 206Diel, IJ
- [44] Radiation recall reaction with anastrozole treatment in breast cancerPRACTICAL RADIATION ONCOLOGY, 2012, 2 (04) : E65 - E68Haydaroglu, AyferSert, FatmaKazandi, Ali CanUnal, Idil
- [45] Anastrozole: A selective aromatase inhibitor for the treatment of breast cancerAMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (05) : 445 - 452Higa, GMAlKhouri, N
- [46] Results of the german ARIMIDEX® in the adjuvant therapy of not advanced breast cancer evaluation (AWB003) evaluating the safety, tolerability and acceptance of anastrozole (ARIMIDEX®) in postmenopausal, hormone receptor positive women under daily practice conditionsONKOLOGIE, 2008, 31 : 47 - 48Bani, M.Engel, J.Lux, M. P.Rauh, C.Eder, I.Bani, H.Jud, S.Breuel, C.Bach, A.Beckmann, M. W.Fasching, P. A.
- [47] The ARIBON study: Reversal of anastrozole (Arimidex) induced bone loss with oral monthly ibandronate (Bondronat) treatment during adjuvant therapy for breast cancer.CANCER TREATMENT REVIEWS, 2006, 32 : S48 - S49Lester, J. E.Gutcher, S. A.Ellis, S.Thorpe, R.Horsman, J.Brown, J. E.Purohit, O. P.Dodwell, D.Coleman, R. E.
- [48] Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women:: Results of the tamoxifen or arimidex randomized group efficacy and tolerability studyJOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) : 3748 - 3757Bonneterre, JThürlimann, BRobertson, JFRKrzakowski, MMauriac, LKoralewski, PVergote, IWebster, ASteinberg, Mvon Euler, M
- [49] Cost analysis of treatment-related adverse events with anastrozole (Arimidex) versus tamoxifen in postmenopausal women with hormone receptor-positive (HR+) advanced breast cancer (ABC): a UK perspectiveEUROPEAN JOURNAL OF CANCER, 2002, 38 : S131 - S131Simons, RBassi, RJones, DBarrett-Lee, P